TrialNature medicine2021
A trial of gantenerumab or solanezumab in dominantly inherited Alzheimer's disease.
Stephen Salloway et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
202 papers cite itlatest 60 shown
this paperpooled ittrialcites it